Pacific Historical Income Statement
| PACB Stock | USD 1.91 0.15 8.52% |
Historical analysis of Pacific Biosciences income statement accounts such as Other Operating Expenses of 561.7 M, Research Development of 196.5 M, Total Operating Expenses of 406.6 M or Total Other Income Expense Net of 17.1 M can show how well Pacific Biosciences of performed in making a profits. Evaluating Pacific Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Pacific Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Pacific Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pacific Biosciences is a good buy for the upcoming year.
Pacific |
About Pacific Income Statement Analysis
Pacific Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Pacific Biosciences shareholders. The income statement also shows Pacific investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Pacific Biosciences Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Pacific Biosciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Pacific Biosciences of minus its cost of goods sold. It is profit before Pacific Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pacific Biosciences. It is also known as Pacific Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Pacific Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Pacific Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At present, Pacific Biosciences' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 15.1 M, whereas Gross Profit is forecasted to decline to about 28.1 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 58.9M | 49.0M | 52.8M | 28.1M | Total Revenue | 130.5M | 128.3M | 200.5M | 210.5M |
Pacific Biosciences income statement Correlations
Click cells to compare fundamentals
Pacific Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pacific Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 9.9M | 9.3M | 11.6M | 17.3M | 26.5M | 27.9M | |
| Interest Expense | 2.6M | 267K | 12.5M | 14.7M | 14.3M | 15.1M | |
| Total Revenue | 90.9M | 78.9M | 130.5M | 128.3M | 200.5M | 210.5M | |
| Gross Profit | 34.6M | 32.6M | 58.9M | 49.0M | 52.8M | 28.1M | |
| Other Operating Expenses | 191.4M | 183.3M | 308.7M | 433.1M | 535.0M | 561.7M | |
| Operating Income | (100.5M) | (104.4M) | (178.2M) | (304.8M) | (334.5M) | (317.7M) | |
| Ebit | (109.5M) | 29.7M | (262.3M) | (299.6M) | (303.8M) | (288.6M) | |
| Research Development | 59.6M | 64.2M | 112.9M | 193M | 187.2M | 196.5M | |
| Ebitda | (99.5M) | 39.0M | (250.8M) | (282.2M) | (277.3M) | (263.4M) | |
| Total Operating Expenses | 135.1M | 137.0M | 237.0M | 353.9M | 387.2M | 406.6M | |
| Income Before Tax | (84.1M) | 29.4M | (274.9M) | (314.2M) | (318.2M) | (302.3M) | |
| Total Other Income Expense Net | 16.4M | 133.8M | (96.7M) | (9.4M) | 16.3M | 17.1M | |
| Net Income | (77.8M) | 29.4M | (181.2M) | (296.9M) | (306.7M) | (291.4M) | |
| Income Tax Expense | (6.3M) | (7.0M) | (93.6M) | (17.3M) | (11.4M) | (12.0M) | |
| Cost Of Revenue | 56.3M | 46.3M | 71.7M | 79.3M | 147.7M | 155.1M | |
| Selling General Administrative | 75.5M | 72.8M | 124.1M | 160.9M | 168.8M | 177.3M | |
| Net Income From Continuing Ops | (102.1M) | (102.6M) | (181.2M) | (314.2M) | (309.1M) | (293.6M) | |
| Non Operating Income Net Other | 848K | 1.0M | 2.1M | 93K | 107.0K | 101.6K | |
| Net Income Applicable To Common Shares | (84.1M) | 29.4M | (181.2M) | (314.2M) | (282.8M) | (268.7M) | |
| Net Interest Income | (2.6M) | (267K) | (12.5M) | (14.7M) | (14.4M) | (13.7M) | |
| Reconciled Depreciation | 9.9M | 9.3M | 11.6M | 17.3M | 19.4M | 13.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share 0.64 | Quarterly Revenue Growth (0.28) | Return On Assets (0.11) | Return On Equity (0.65) |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.